Document Detail


All-cause mortality of patients with dyslipidemia up to 19 years after a multidisciplinary lifestyle modification programme: a randomized trial.
MedLine Citation:
PMID:  20700054     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
BACKGROUND: Many studies have shown that individual lifestyle factors are associated with cardiovascular mortality and all-cause mortality. Observational studies of comprehensive programmes have reported risk reductions. The objectives were to assess the long-term all-cause mortality by diagnosis in patients referred to a lifestyle modification programme, aimed at combating coronary heart disease and stroke.
METHODS: A randomized trial with 325 patients referred to the centre between 1988 and 1989 for dyslipidemia, hypertension, type 2 diabetes and coronary heart disease; 239 patients were randomized to the programme, 86 randomized to usual care. Cases were admitted to the centre in groups of 30 for a 4-week residential comprehensive activity, in total 114 full-time hours, focusing on food preferences and selections, and physical exercise. The activities were repeated during a 4-day revisit to the centre 1 year and 5 years after the 4-week intervention. Controls were referred back to their doctors, mainly in primary care, for usual care. Main outcome measure was all-cause mortality during 11–12 and 18–19 years after intervention.
RESULTS: At follow-up 11–12 years after referral, the relative risk reduction (RRR) was 76% with the intention-to-treat analysis among cases admitted for dyslipidemia (hazards ratio 0.24, confidence interval 0.06–0.89, P = 0.033). After 18–19 years, the RRR was 66% (hazards ratio 0.34, confidence interval 0.13–0.88, P = 0.026). No RRR was found for the other three diagnoses.
CONCLUSION: Patients admitted for dyslipidemia reached a real long-term RRR of all-cause mortality. They had by definition a need for this programme.
Authors:
Lena Håglin; Sara Lundström; Gunnar Kaati; Lennart Bäckman; Lars Olov Bygren
Related Documents :
17513654 - Magnesium as an adjuvant to postoperative analgesia: a systematic review of randomized ...
16472924 - Effectiveness of stereotactic radiosurgery alone or in combination with whole brain rad...
15841194 - Switching from donepezil to rivastigmine is well tolerated: results of an open-label sa...
9280034 - A bayesian strategy for evaluating treatments applicable only to a subset of patients.
12043774 - Transtrochanteric valgus osteotomy for the treatment of osteoarthritis of the hip secon...
22408744 - Non-bismuth quadruple therapy for first-line helicobacter pylori eradication: a randomi...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology     Volume:  18     ISSN:  1741-8275     ISO Abbreviation:  Eur J Cardiovasc Prev Rehabil     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-06-01     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101192000     Medline TA:  Eur J Cardiovasc Prev Rehabil     Country:  England    
Other Details:
Languages:  eng     Pagination:  79-85     Citation Subset:  IM    
Affiliation:
Department of Public Health and Clinical Medicine, Family Medicine, University of Umeå, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Early detection of acute posterior myocardial infarction using body surface mapping and SPECT scanni...
Next Document:  Prevalence, treatment and control of dyslipidaemia in Switzerland: still a long way to go.